Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 10/20 | 0.44 |
| ▸ | SLC8A1 | P32418 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1767489 | 0.91 | SCD (0.43) | SCDSLC8A1HDAC1 | |
| SCHEMBL17263335 | 0.90 | SCD (0.42) | SCDHDAC1THRBMAPTKDM1A | |
| SCHEMBL1767515 | 0.90 | SCD (0.52) | SCDHDAC1MAPT | |
| SCHEMBL1767464 | 0.88 | HDAC1 (0.49) | SCDHDAC1KDM1A | |
| SCHEMBL1767533 | 0.88 | SCD (0.45) | SCDHDAC1MAPT | |
| SCHEMBL17263326 | 0.85 | SCD (0.45) | SCDHDAC1THRBMAPT | |
| SCHEMBL16160216 | 0.81 | HDAC1 (0.48) | SCDHDAC1MAPTKDM1A | |
| SCHEMBL1767462 | 0.81 | SCD (0.41) | SCDHDAC1 | |
| SCHEMBL1767688 | 0.80 | SCD (0.50) | SCDHDAC1MAPTL3MBTL1 | |
| SCHEMBL17263331 | 0.80 | SCD (0.44) | SCDHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160289191-A1 | ORGANIC COMPOUNDS | XENON PHARMACEUTICALS INC. (CA) | 2016-10-06 | — | — | US | disclosed |
| US-9187426-B2 | Organic compounds | NOVARTIS AG (CH) | 2015-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289191-A1 | ORGANIC COMPOUNDS | SCD, SCD5, FADS2 | SCD 1/4885SLC8A1 4335/4885HDAC1 136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.